Stockreport

Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]

Cabaletta Bio, Inc.  (CABA) 
PDF IND amendment cleared to manufacture rese-cel with the automated, scalable Cellares platform based on multiple successful engineering runs; clinical manufacturing data [Read more]